GE HealthCare Technologies Inc. GEHC
66.63
0.25
0.38%
as of 25 Sep
- Market cap
- $29.9B
- P/E
- 15.3×
Follow GEHC
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
GE HealthCare Technologies Inc. (GEHC) P/B ratio
As of 25 September 2026, GE HealthCare Technologies Inc. (GEHC) trades at a P/B ratio of 2.7×. Over the past ten years it has ranged from 1.5× (December 2022) to 6.0× (March 2024); the current reading is higher than 8% of that period. That is above the Medical Devices industry median of 2.5× and above the Healthcare sector median of 2.5×.
P/B ratio, daily
Annual
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 3.6× | (14.54%) |
| FY2024 | 4.2× | (13.39%) |
| FY2023 | 4.9× | 79.08% |
| FY2022 | 2.7× | 68.27% |
| FY2021 | 1.6× | 0.00% |
| FY2020 | 1.6× | 0.00% |
| FY2019 | 1.6× | — |
Quarterly
| Period | P/B ratio | Change |
|---|---|---|
| Jun 2026 | 2.6× | (13.17%) |
| Mar 2026 | 3.0× | (15.57%) |
| Dec 2025 | 3.6× | 5.29% |
| Sep 2025 | 3.4× | (1.69%) |
| 14 more quarters | Free account |
Against its own ten years
Low 1.5×
High 6.0×
Ten-year median
4.2×
Current reading's percentile
8
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| ZBH Zimmer Biomet Holdings, Inc. compare | 1.4× |
| PHG Koninklijke Philips N.V. compare | 1.8× |
| SNN Smith & Nephew SNATS, Inc. compare | 2.3× |
| BSX Boston Scientific Corporation compare | 2.6× |
| GEHC GE HealthCare Technologies Inc. | 2.7× |
| STE STERIS plc compare | 2.8× |
| EW Edwards Lifesciences Corporation compare | 4.6× |
| PEN Penumbra, Inc. compare | 8.2× |
| DXCM DexCom, Inc. compare | 12.6× |
| Medical Devices industry median | 2.5× |
| Healthcare sector median | 2.5× |
| Market median | 1.8× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on GEHC
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement